BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 16608077)

  • 1. [Cathepsin B expression and malignances and angiogenesis in gliomas].
    Tang JJ; Jiang S; Mao BY
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Mar; 37(2):212-4, 225. PubMed ID: 16608077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Correlation of hTERT expression to maspin and bFGF expression and their significance in glioma].
    Wang DL; Wang YF; Shi GS; Huang H
    Ai Zheng; 2007 Jun; 26(6):601-6. PubMed ID: 17562265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survivin expression and its relation with proliferation, apoptosis, and angiogenesis in brain gliomas.
    Zhen HN; Zhang X; Hu PZ; Yang TT; Fei Z; Zhang JN; Fu LA; He XS; Ma FC; Wang XL
    Cancer; 2005 Dec; 104(12):2775-83. PubMed ID: 16284993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Study on the expression of BDNF in human gliomas].
    Yan Q; Yu HL; Li JT
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 May; 40(3):415-7. PubMed ID: 19626994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cathepsin B on invasion and metastasis of gastric carcinoma.
    Liu Y; Xiao S; Shi Y; Wang L; Ren W; Sloane BF
    Chin Med J (Engl); 1998 Sep; 111(9):784-8. PubMed ID: 11155666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Degradation of extracellular matrix protein tenascin-C by cathepsin B: an interaction involved in the progression of gliomas.
    Mai J; Sameni M; Mikkelsen T; Sloane BF
    Biol Chem; 2002 Sep; 383(9):1407-13. PubMed ID: 12437133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cathepsin D is a potential serum marker for poor prognosis in glioma patients.
    Fukuda ME; Iwadate Y; Machida T; Hiwasa T; Nimura Y; Nagai Y; Takiguchi M; Tanzawa H; Yamaura A; Seki N
    Cancer Res; 2005 Jun; 65(12):5190-4. PubMed ID: 15958563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of tissue factor pathway inhibitor 2 inversely correlates during the progression of human gliomas.
    Rao CN; Lakka SS; Kin Y; Konduri SD; Fuller GN; Mohanam S; Rao JS
    Clin Cancer Res; 2001 Mar; 7(3):570-6. PubMed ID: 11297250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The value and correlation between PRL-3 expression and matrix metalloproteinase activity and expression in human gliomas.
    Kong L; Li Q; Wang L; Liu Z; Sun T
    Neuropathology; 2007 Dec; 27(6):516-21. PubMed ID: 18021371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic impact of CD68 and kallikrein 6 in human glioma.
    Strojnik T; Kavalar R; Zajc I; Diamandis EP; Oikonomopoulou K; Lah TT
    Anticancer Res; 2009 Aug; 29(8):3269-79. PubMed ID: 19661345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathologic significance of cystatin C expression in gliomas.
    Nakabayashi H; Hara M; Shimuzu K
    Hum Pathol; 2005 Sep; 36(9):1008-15. PubMed ID: 16153465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Total and lipid-bound plasma sialic acid as diagnostic markers in colorectal cancer patients: correlation with cathepsin B expression in progression to Dukes stage.
    Sebzda T; Saleh Y; Gburek J; Warwas M; Andrzejak R; Siewinski M; Rudnicki J
    J Exp Ther Oncol; 2006; 5(3):223-9. PubMed ID: 16528972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of cathepsin B and microvascular density increases with higher grade of astrocytomas.
    Wang M; Tang J; Liu S; Yoshida D; Teramoto A
    J Neurooncol; 2005 Jan; 71(1):3-7. PubMed ID: 15719267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunolocalization of cathepsin B in human glioma: implications for tumor invasion and angiogenesis.
    Mikkelsen T; Yan PS; Ho KL; Sameni M; Sloane BF; Rosenblum ML
    J Neurosurg; 1995 Aug; 83(2):285-90. PubMed ID: 7542317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study of correlation between expression of bradykinin B2 receptor and pathological grade in human gliomas.
    Zhao Y; Xue Y; Liu Y; Fu W; Jiang N; An P; Wang P; Yang Z; Wang Y
    Br J Neurosurg; 2005 Aug; 19(4):322-6. PubMed ID: 16455538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cathepsin B expression and localization in glioma progression and invasion.
    Rempel SA; Rosenblum ML; Mikkelsen T; Yan PS; Ellis KD; Golembieski WA; Sameni M; Rozhin J; Ziegler G; Sloane BF
    Cancer Res; 1994 Dec; 54(23):6027-31. PubMed ID: 7954439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delta-like ligand 4 correlates with endothelial proliferation and vessel maturation in human malignant glioma.
    Li ZQ; Gong LL; Wen ZH; Wang J; Xu CS; Huang XD
    Onkologie; 2012; 35(12):763-8. PubMed ID: 23207622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of PINCH protein in gliomas and its clinicopathological significance.
    Wang MW; Gu P; Zhang ZY; Zhu ZL; Li YM; Zhao HX; Sun XF
    Oncology; 2007; 72(5-6):343-6. PubMed ID: 18187956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of interleukin (IL)-8 expression in human astrocytomas: associations with IL-6, cyclooxygenase-2, vascular endothelial growth factor, and microvessel morphometry.
    Samaras V; Piperi C; Levidou G; Zisakis A; Kavantzas N; Themistocleous MS; Boviatsis EI; Barbatis C; Lea RW; Kalofoutis A; Korkolopoulou P
    Hum Immunol; 2009 Jun; 70(6):391-7. PubMed ID: 19332096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cathepsin B and its inhibitor stefin A in brain tumors.
    Strojnik T; Zajc I; Bervar A; Zidanik B; Golouh R; Kos J; Dolenc V; Lah T
    Pflugers Arch; 2000; 439(3 Suppl):R122-3. PubMed ID: 10653164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.